Tesla Motors Inc (TSLA)’s 10 Biggest Hedge Fund Backers
In the latest round of 13F filings, Philippe Laffont's Coatue Management was the largest Tesla Motors Inc (NASDAQ:TSLA) shareholder, reporting a $76.2 million stake, which contains...
Posts Tagged ‘Roberto Mignone Bridger Management’
Do Hedge Funds and Insiders Love Alnylam Pharmaceuticals, Inc. (ALNY)?
To most traders, hedge funds are assumed to be unimportant, old investment vehicles of years past.
SHFL entertainment Inc (SHFL): Insiders Aren’t Crazy About It
Is SHFL entertainment Inc (NASDAQ:SHFL) a marvelous investment today? Prominent investors are betting on the stock.
Is Team Health Holdings LLC (TMH) Going to Burn These Hedge Funds?
Team Health Holdings LLC (NYSE:TMH) was in 26 hedge funds' portfolio at the end of the first quarter of 2013.
ISIS Pharmaceuticals, Inc. (ISIS): Hedge Funds and Insiders Are Bearish, What Should You Do?
ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) was in 5 hedge funds' portfolio at the end of December.
Hedge Funds Aren’t Crazy About Cott Corporation (USA) (COT) Anymore
Cott Corporation (USA) (NYSE:COT) was in 10 hedge funds' portfolio at the end of December.
Is SHFL entertainment Inc (SHFL) Going to Burn These Hedge Funds?
SHFL entertainment Inc (NASDAQ:SHFL) was in 11 hedge funds' portfolio at the end of December. SHFL has experienced an increase in hedge fund interest in recent months.
Pactera Technology Intl Ltd (ADR) (PACT): Are Hedge Funds Right About This Stock? – Velti Plc (VELT), Datawatch Corporation (DWCH)
Is Pactera Technology Intl Ltd (ADR) (NASDAQ:PACT) a good stock to buy now? The smart money is taking an optimistic view.
This Metric Says You Are Smart to Sell Ironwood Pharmaceuticals, Inc. (IRWD): PerkinElmer, Inc. (PKI), WuXi PharmaTech (Cayman) Inc. (ADR) (WX)
In the 21st century investor’s toolkit, there are a multitude of indicators investors can use to monitor their holdings.
Hedge Funds Are Betting On Alnylam Pharmaceuticals, Inc. (ALNY): Arena Pharmaceuticals, Inc. (ARNA), Acorda Therapeutics Inc (ACOR)
Is Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) a first-rate stock to buy now? Investors who are in the know are turning bullish.
Hyatt Hotels Corporation (NYSE:H): Are Hedge Funds Right About This Stock?
If you'd ask most traders, hedge funds are perceived as underperforming, old financial vehicles of the past.
This Metric Says You Are Smart to Buy Rent-A-Center Inc (NASDAQ:RCII)
If you'd ask most stock holders, hedge funds are perceived as slow, old financial vehicles of yesteryear.
Hedge Funds Are Crazy About Idenix Pharmaceuticals Inc (NASDAQ:IDIX)
Is Idenix Pharmaceuticals Inc (NASDAQ:IDIX) the right investment to pursue these days? The smart money is in an optimistic mood.
iStar Financial Inc. (NYSE:SFI): Insiders Are Buying, Should You?
To most investors, hedge funds are seen as worthless, old investment vehicles of yesteryear.
These Insiders Were Selling Apple Inc. (AAPL)…They Were Right
Apple Inc. (NASDAQ:AAPL) had few critics six months ago, when its stock price had eclipsed $700 a share, and some analysts were calling for $1,000-price targets.
Billion Dollar Bridger Management’s New Stock Picks: UnitedHealth Group Inc. (UNH), United Rentals, Inc. (URI), Priceline.com Inc (PCLN)
Roberto Mignone of Bridger Management recently released its 13F filing with the SEC for the final quarter of 2012, giving the public insight into the secretive hedge fund manager...
‘Hedge Hunter’ Roberto Mignone’s Favorite Investments: General Motors Company (GM), Morgan Stanley (MS), Google Inc (GOOG)
Despite the fact that hedge funds are often viewed as slow and underperforming investment vehicles of the financial world of yesteryear, there are still ways to parse the data...
Assured Guaranty Ltd. (AGO), Tripadvisor Inc (TRIP): Do You Own This $2 Billion Hedge Fund’s Best Stock Picks?
Smaller cap stocks don't get as much attention from bankers, analysts, and most other investors.
Roberto Mignone’s Top Stock Picks
Roberto Mignone established Bridger Management in July 2000, right before he turned 29 years old.
Insider Trading: Samuel Isaly’s Orbimed Advisors is Selling $ANTH
Samuel Isaly’s Orbimed Advisors filed for its recent insider sales in Anthera Pharmaceuticals Inc (ANTH) on November 18th.
Bridger Management’s Top Stock Picks
Roberto Mignone's Bridger Management reported to own $1.2 billion worth of S&P 500 (SPY) call options at the end of September, increasing the position by 843% from the end of...
Hedge Funds Lose Big After Ctrip $CTRP Share Prices Fall Over 12%
Ctrip.com (CTRP) share prices fell over 12% on Monday after reporting a disappointing sales outlook for the fourth quarter.
Hedge Funds Make a Bundle on Inhibitex $INHX
Shares of Inhibitex (INHX) more than doubled Friday morning.
Hedge Funds Make a Bundle After Boston Beer $SAM Grows 14.63% Wed
The Boston Beer Company (SAM) swelled from $86.37 at close on Tuesday to hit $99.01 a share at close on Wednesday.
Samana Capital Reported 6% Stake in $ONXX
Samana Capital reported 6% passive stake in Onyx Pharmaceuticals Inc (ONXX) on October 24th. According to the filing, Samana Capital now possesses 3.84 million shares in ONXX.
Roberto Mignone’s Bridger Management Boosts Its Position in $CRME
Roberto Mignone’s Bridger Management boosts its position in Cardiome Pharma Corp (CRME).
Roberto Mignone’s New Stock Picks
When Roberto Mignone graduated from Harvard Business School, he joined John Griffin at Blue Ridge Capital.
Hedge Funds Hammered in Research In Motion $RIMM
Research In Motion (RIMM) is down more than 22% after disclosing that revenue and profits will miss expectations.
Do Julian Robertson’s Tiger Cubs Have Alpha?
Julian Robertson is a hedge fund legend.
Bill Ackman’s and Hedge Funds’ General Motors $GM Disappointment
Bill Ackman is one of the most successful activist investors and his 13D disclosures make a huge impact in the marketplace.
John Murphy’s Alydar Capital Buys Medifast, Sodastream, and Knology
Boston-based Alydar Capital is a long-short hedge fund managing more than $2 Billion. The fund was founded by John A. Murphy in 2003.
Roberto Mignone’s Bullish Stock Picks
Roberto Mignone's Bridger Management follows a long/short strategy after extensively researching companies. Their analysts do the legwork and dig deep by visiting companies...
Roberto Mignone and Bridger Management’s Portfolio and New Stock Picks
Roberto Mignone’s Bridger Management keeps their returns extremely secret. They do extensive analysis and follow a long/short strategy.
